GLP-1 Weight Loss Medications: Customers in the 6-month cohort lost an average of 20.9 pounds, or 10.3% of their initial body weight
For the same 220-pound person, 22.5% means losing roughly 50 pounds, nearly 17 more pounds than semaglutide would produce on average
In 56-week studies, patients taking Contrave alongside diet and exercise lost an average of 5-9% of their body weight, compared to 1-5% with a placebo, meaning the medication contributed roughly 4-5 percentage points of additional weight loss.4,5 About 46% of patients on Contrave achieved at least 5% weight loss by week 16
Patient assistance programs from manufacturers could be expanded to reach a broader range of low-income patients
P.ShimadaY
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and antioxidant pathways, including variants affecting glutathione synthesis (GCLC), oxidative stress resilience (SOD2, CAT), and thyroid autoimmunity (HLA, CTLA4)